Quantcast

Latest antibodies Stories

2014-05-07 04:22:16

OXFORD, England and SAN JOSE, May 7, 2014 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer, announced today that it has obtained the exclusive global rights to certain Xenomouse(R) antibodies generated by Amgen and to ImmunoGen's maytansinoid ADC technology for an undisclosed target. The rights were granted under the existing strategic...

2014-05-02 23:00:27

The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides (http://www.marketsandmarkets.com/Market-Reports/biosimilars-40.html). (PRWEB) May 03, 2014 Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast...

2014-04-30 08:33:09

Proprietary "Smart Antibodies" Allow for Selective Activation in Cancerous Tissues SAN DIEGO, April 30, 2014 /PRNewswire/ -- BioAtla, a global biotechnology company focused on the development of differentiated biological therapeutics, today announced that the United States Patent and Trademark Office (USPTO) has issued to BioAtla U.S. Patent No. 8,709,755, its first patent directed to methods of generating conditionally active antibodies. Conditionally active antibodies are...

2014-04-29 20:27:42

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Flow Cytometry: Products, Technologies and Global Marketshttp://www.reportbuyer.com/pharma_healthcare/technology/flow_cytometry_products_technologies_global_markets.html INTRODUCTIONBCC Research measures and segments the flow cytometry market on the basis of instruments, reagents, software, services, technologies, applications and end users. Key instruments discussed in the report include...

Two Separate Studies On MERS-Coronavirus Offer Better Understanding Of Newly Emerging Disease
2014-04-29 09:33:16

Lawrence LeBlond for redOrbit.com - Your Universe Online Two separate studies this week are helping scientists gain a better understanding of the dangerous Middle East respiratory syndrome (MERS) coronavirus, a disease that has sickened more than 300 people and left at least a hundred dead since it was first reported in September 2012. HUMAN ANTIBODIES The first study comes from scientists at Dana-Farber Cancer Institute who have identified natural human antibodies against the virus...

2014-04-29 08:35:33

MONROVIA, Calif., April 29, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will present at the Deutsche Bank 39th Annual Health Care Conference on Wednesday, May 7, 2014 at 4:50 p.m. EDT in Boston, MA. A live audio webcast of the...

2014-04-28 23:05:53

A new blood test that has the potential to diagnose Alzheimer’s disease in an individual and significantly advances drug testing and research on the disease, has been developed through grant funding by the Cure Alzheimer's Fund. Boston, MA (PRWEB) April 28, 2014 A new blood test that has the potential to diagnose Alzheimer’s disease in an individual and significantly advances drug testing and research on the disease, has been developed through grant funding by the Cure...

2014-04-28 12:31:23

Company scientists advance understanding of role of genetics in seizure disorders, Charcot-Marie-Tooth disease and other conditions at top neurology industry conference MADISON, N.J., April 28, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that several scientists from its Athena Diagnostics specialty neurology business will present research during the the American Academy of Neurology's 66th Annual...

2014-04-24 12:30:09

NEW YORK, April 24, 2014 /PRNewswire-USNewswire/ -- Scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) have discovered a new vulnerable site on HIV that antibodies can attack to prevent infection from a broad range of the virus' many variants. http://photos.prnewswire.com/prnvar/20131210/DC30761LOGO "HIV has very few known sites of vulnerability, but in this work we've described a new one, and we expect it will be useful in developing a...

2014-04-23 08:31:11

ROCKVILLE, Md., April 23, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today positive preclinical research findings for SYN-005, the Company's proprietary monoclonal antibody (mAb) combination therapy for treating Pertussis (whooping cough), in two non-human primate studies (n=15). In the second pertussis study in...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related